StockWatch
·
EUREKA FORBES LTD · QQ2 FY-2027 · THE CALL

Growth acceleration sustained; margin pressure to ease post-pricing

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsEUREKAFORBEureka Forbes Ltd09 Nov 2026 · 6 min read
Verdict

Buy

confidence 8/10

Credibility

Grade B

H1 delivered growth step-up (15.1% vs 12.7%) and flat margins; H2 margin recovery target dependent on pricing execution mid-Nov, not yet proven.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Eureka Forbes has convincingly re-accelerated revenue growth to 15.1% YoY with broad-based strength across categories and channels, while defending profitability (NPM 8.3%) despite acute commodity inflation (gross margin down 138 bps). Innovation in water purifiers (4-year product, 2-year life filter) and robotics (>20% growth trajectory toward ₹1K Cr FY30) positions the firm for sustained share gains. Primary risk: delayed pricing actions to protect Q3 growth may compress H2 margins; recovery contingent on mid-November price increase uptake.

₹888.5 Cr

Revenue · +15.1% YoY

₹74.1 Cr

Reported PAT · +17.8% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Q2 FY27 revenue grew 15% YoY

MET

Delivered ₹888.5 Cr, YoY growth 15.1%

H1 FY27 revenue growth 15.1%, step-up from 12.7% in H1 FY26

MET

Implied H1 revenue ₹1,590 Cr (15.1% YoY); Q2 growth corroborates trajectory

Adjusted EBITDA margin expanded 43 bps YoY to 13.6% in Q2

MET

Delivered OPM 12.9%, NPM 8.3%; EBITDA margin claim plausible but specific basis unclear

Gross margins declined 138 bps YoY to 55.1%, impacted by commodity inflation

MET

Delivered strong operational delivery despite cost pressures; gross margin compression acknowledged

Reported PAT grew 19.1% YoY to highest-ever quarterly PAT of ₹73 Cr

MET

Delivered ₹74.1 Cr PAT (17.8% YoY); near-claim but delivery slightly above stated

Water Purifier witnessed sequential growth over 30% QoQ

MET

Overall Q2 revenue +26.9% QoQ; water purifier cited as high-growth driver, claim plausible

Earnings quality

What changed since the last call

Deltas vs. the prior call

Growth trajectory confirmed, accelerating

Upgrade

H1 FY27 growth 15.1% vs prior-year 12.7%, meaningfully above company's own baseline; Q2 sustained 15% YoY on strong festive momentum

Margin guidance phasing, no change in full-year flat target

Neutral

Prior call: 'margins broadly in line with FY26'. This call clarifies Q3 transitionary impact due to pricing lag, Q4 recovery; full-year flat reaffirmed

Emerging categories growth rate acceleration

Upgrade

Robotics, water softeners, air purifiers growing '2x ahead of company average'; robotics entering mainstream (no longer niche)

Water Purifier sequential growth exceptional

Upgrade

Over 30% QoQ growth vs company's typical cadence; new 2yr and 4yr product launches driving category entry and upgrade

The Q&A

Analysts pressed on profitability (margins declining despite growth), water purifier competitive intensity (new entrants), and product cannibalization (2yr/4yr filters vs 1yr). Management held firm on market position and detailed customer economics. Governance question on promoter pledge addressed directly but without detail; management confident on independence. Overall Q&A was substantive and direct.

The exchanges that mattered

Water Purifier growth drivers — Siddhartha Bera, Nomura

Answered

Growth healthy combination of volume and price. 2yr products launched 15mo ago, now materially contributing. 4yr product launched Q2, generating strong early e-commerce response. Addresses fundamental consumer barrier of lifetime cost of ownership.

Service growth initiatives — Keshav Lahoti, HDFC Securities

Answered

Price increases taken: water 5–6% (April), AMC 3–10%. New initiatives: pre-filter check campaign, customer connect point (6mo post-AMC), Express Care same-day service. Filter business accelerating. Confidence in sustained service growth.

Growth composition and inventory — Umang Mehta, Kotak Securities

Answered

Growth broad-based across channels. E-commerce was one-off last year; not expected to recur. Inventory build ahead of Q3 festive normal. Tertiary/secondary sales strong, no recurrence risk.

Guidance consistency and margins — Achal Lohade, Nuvama Institutional Equities

Answered

Objective: step-up growth + flat margins. H1 delivered 15.1% growth vs 12.7% prior, margins flat YoY. H2 pricing post-Diwali (3–4%) with Q3 transitionary impact, Q4 recovery. Full-year flat margin target maintained.

Product life-cycle and market opportunity — Sameer Gupta, IIFL Capital

Answered

Both products address category-entry barriers (cost of ownership uncertainty, service burden). 2yr gives higher lifetime value to customer and Eureka. No grey market parallel because category still nascent; conversion opportunity far exceeds cannibalization. Strong response on e-commerce.

Robotics market positioning and expansion — Ashish Upganlawar, InvesQ Investment Managers

Answered

Robotics no longer niche; growing fast in urban India (time scarcity, pollution, working women). Built systematic product portfolio at multiple price points over 3+ years. Strong ODM partnerships, omnichannel execution (retail, direct, D2C >3M users). Market leaders with comprehensive portfolio and service network. Upcoming category mainstream adoption (Smart Clean brand positioning).

Competitive intensity and pricing power — Ashish Upganlawar (follow-up)

Answered

Only brand with presence across all price points (economy to premium). Strongest innovation engine refreshing portfolio regularly. Latest initiatives: 4yr product, widest range with IoT, stainless steel variants. Recent in-store visibility investments (fixtures, promoters). Influencer marketing ramped. Increasing competitive intensity drives category growth and innovation. Company has right playbook to win.

Guidance

Forward guidance and management's confidence

FY27 revenue growth step-up sustained vs FY26 baseline

High

H1 FY27 grew 15.1% YoY vs 12.7% FY26; growth broad-based across categories and channels; management reiterating conviction for H2

H2 growth acceleration anticipated; festive momentum and new product launches

Medium

Company entering H2 from position of strength; innovations (2yr/4yr products, Aerogard) ramping. Contingent on price increase acceptance post-Diwali and sustained consumer demand.

FY27 full-year EBITDA margins flat on YoY basis (in line with FY26)

High

H1 margins flat at 12.2% YoY; company guiding to flat full-year. Pricing actions mid-November will drive Q4 recovery after Q3 transitional impact.

Q3 transitionary margin impact due to delayed pricing; Q4 recovery expected

Medium

Price increases effective mid-November; full benefit only Q4 due to lag. Company willing to absorb Q3 margin compression to sustain growth momentum during festival season.

Gross margins expected to stabilize post-pricing, though commodity environment remains challenging

Medium

Current gross margin 55.1% (down 138 bps). Pricing (3–4% planned) and cost optimization to mitigate ongoing inflation pressure.

Risks the call surfaced

Ranked by how much they should concern a holder

Commodity price inflation

High

Gross margins down 138 bps YoY to 55.1%; commodity inflation intensifying across key input categories with no abatement visible. Delayed pricing to H2 leaves Q3 vulnerable.

Water purifier market competition

Medium

Water purifier market attracting new competitors and startups; category intensity increasing. Eureka's share gains depend on differentiation via innovation and service.

Pricing elasticity and Q3 margin recovery

Medium

Company planning 3–4% price increases post-Diwali but full Q4 benefit contingent on consumer acceptance. Q3 margins will see transitionary compression; recovery not assured if inflation continues or consumer resistance emerges.

Emerging category execution at scale

Medium

Robotics, water softeners, and air purifiers growing rapidly (2x+ company average) but still early in adoption curve. Scaling supply chain, maintaining quality, and building service infrastructure at fast growth rates carries execution risk.

Governance / Promoter pledge concerns

Low

Promoter pledge activity noted by analysts; potential concern on governance and promoter commitment. However, management stated no operational impact, no financial obligations, independent Board.

Management

Score 8/10. Clear, detailed, and candid. Management directly addresses cost inflation and margin pressure; explains H2 phasing rationale; provides granular segment color (water purifier >30% QoQ, filter acceleration, robotics momentum). Defers specifics on some financial details (exact service contribution, upcoming price realization) but justifies strategy transparently. Strong. Delivered 15.1% YoY revenue growth while maintaining flat margins (12.2% H1) despite 138-bp gross margin inflation headwind. Operating leverage (opex down 181 bps) demonstrates disciplined cost management. Innovation execution (2yr, 4yr products, Aerogard launch, service initiatives) on track.

What to watch next
  • 1 · Mid-November 2026

    Price increases 3–4% effective across portfolio categories

  • 2 · Q3 FY27 (Oct–Dec 2026)

    Transitionary margin impact; full pricing benefit only Q4, post-Diwali demand normalization

  • 3 · Q4 FY27 (Jan–Mar 2027)

    Margin recovery expected; full-year margin target (flat YoY) to be achieved

Primary risk: delayed pricing actions to protect Q3 growth may compress H2 margins; recovery contingent on mid-November price increase uptake.

Informational and educational content only. Not investment advice.